157 related articles for article (PubMed ID: 34964932)
1. Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients.
Bourigault P; Skwarski M; Macpherson RE; Higgins GS; McGowan DR
EJNMMI Res; 2021 Dec; 11(1):130. PubMed ID: 34964932
[TBL] [Abstract][Full Text] [Related]
2. Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.
Bourigault P; Skwarski M; Macpherson RE; Higgins GS; McGowan DR
Sci Rep; 2022 Dec; 12(1):21746. PubMed ID: 36526815
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.
Skwarski M; McGowan DR; Belcher E; Di Chiara F; Stavroulias D; McCole M; Derham JL; Chu KY; Teoh E; Chauhan J; O'Reilly D; Harris BHL; Macklin PS; Bull JA; Green M; Rodriguez-Berriguete G; Prevo R; Folkes LK; Campo L; Ferencz P; Croal PL; Flight H; Qi C; Holmes J; O'Connor JPB; Gleeson FV; McKenna WG; Harris AL; Bulte D; Buffa FM; Macpherson RE; Higgins GS
Clin Cancer Res; 2021 May; 27(9):2459-2469. PubMed ID: 33597271
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
van Elmpt W; Zegers CML; Reymen B; Even AJG; Dingemans AC; Oellers M; Wildberger JE; Mottaghy FM; Das M; Troost EGC; Lambin P
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):240-248. PubMed ID: 26338178
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of
Grkovski M; Schwartz J; Rimner A; Schöder H; Carlin SD; Zanzonico PB; Humm JL; Nehmeh SA
EJNMMI Res; 2016 Dec; 6(1):79. PubMed ID: 27822900
[TBL] [Abstract][Full Text] [Related]
6. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
Löck S; Perrin R; Seidlitz A; Bandurska-Luque A; Zschaeck S; Zöphel K; Krause M; Steinbach J; Kotzerke J; Zips D; Troost EGC; Baumann M
Radiother Oncol; 2017 Sep; 124(3):533-540. PubMed ID: 28843726
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial.
Reymen BJT; van Gisbergen MW; Even AJG; Zegers CML; Das M; Vegt E; Wildberger JE; Mottaghy FM; Yaromina A; Dubois LJ; van Elmpt W; De Ruysscher D; Lambin P
Clin Transl Radiat Oncol; 2020 Mar; 21():49-55. PubMed ID: 32021913
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
Wiedenmann N; Bunea H; Rischke HC; Bunea A; Majerus L; Bielak L; Protopopov A; Ludwig U; Büchert M; Stoykow C; Nicolay NH; Weber WA; Mix M; Meyer PT; Hennig J; Bock M; Grosu AL
Radiat Oncol; 2018 Aug; 13(1):159. PubMed ID: 30157883
[TBL] [Abstract][Full Text] [Related]
9. The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
Ashton TM; Fokas E; Kunz-Schughart LA; Folkes LK; Anbalagan S; Huether M; Kelly CJ; Pirovano G; Buffa FM; Hammond EM; Stratford M; Muschel RJ; Higgins GS; McKenna WG
Nat Commun; 2016 Jul; 7():12308. PubMed ID: 27453292
[TBL] [Abstract][Full Text] [Related]
10. Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.
Even AJG; Reymen B; La Fontaine MD; Das M; Mottaghy FM; Belderbos JSA; De Ruysscher D; Lambin P; van Elmpt W
Radiother Oncol; 2017 Dec; 125(3):379-384. PubMed ID: 29122363
[TBL] [Abstract][Full Text] [Related]
11. Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
McGowan DR; Skwarski M; Bradley KM; Campo L; Fenwick JD; Gleeson FV; Green M; Horne A; Maughan TS; McCole MG; Mohammed S; Muschel RJ; Ng SM; Panakis N; Prevo R; Strauss VY; Stuart R; Tacconi EMC; Vallis KA; McKenna WG; Macpherson RE; Higgins GS
Eur J Cancer; 2019 May; 113():87-95. PubMed ID: 30991262
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
13. Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
Kroenke M; Hirata K; Gafita A; Watanabe S; Okamoto S; Magota K; Shiga T; Kuge Y; Tamaki N
PLoS One; 2019; 14(2):e0213111. PubMed ID: 30818360
[TBL] [Abstract][Full Text] [Related]
14. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457
[TBL] [Abstract][Full Text] [Related]
15. First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.
Thureau S; Piton N; Gouel P; Modzelewski R; Dujon A; Baste JM; Melki J; Rinieri P; Peillon C; Rastelli O; Lequesne J; Hapdey S; Sabourin JC; Bohn P; Vera P
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439254
[TBL] [Abstract][Full Text] [Related]
16.
McGowan DR; Macpherson RE; Hackett SL; Liu D; Gleeson FV; McKenna WG; Higgins GS; Fenwick JD
Med Phys; 2017 Sep; 44(9):4665-4676. PubMed ID: 28644546
[TBL] [Abstract][Full Text] [Related]
17. Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
Arvold ND; Heidari P; Kunawudhi A; Sequist LV; Mahmood U
Technol Cancer Res Treat; 2016 Apr; 15(2):234-42. PubMed ID: 25759424
[TBL] [Abstract][Full Text] [Related]
18. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
Löck S; Linge A; Seidlitz A; Bandurska-Luque A; Nowak A; Gudziol V; Buchholz F; Aust DE; Baretton GB; Zöphel K; Steinbach J; Kotzerke J; Overgaard J; Zips D; Krause M; Baumann M; Troost EGC
Radiother Oncol; 2019 Jun; 135():43-50. PubMed ID: 31015169
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of atovaquone on EpCAM
Fu C; Xiao X; Xu H; Lu W; Wang Y
Exp Ther Med; 2020 Dec; 20(6):286. PubMed ID: 33209130
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry study of
Li H; Xu D; Han X; Ruan Q; Zhang X; Mi Y; Dong M; Guo S; Lin Y; Wang B; Li G
Clin Transl Oncol; 2018 Oct; 20(10):1329-1336. PubMed ID: 29623584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
